| Citation: | GUO Lijuan, MA Fangxu, BAO Jie, WANG Shuang, LI Yi. A model study of biomarkers combined with lung function to predict the risk of acute exacerbations of COPD[J]. Chinese Journal of General Practice, 2026, 24(4): 589-592. doi: 10.16766/j.cnki.issn.1674-4152.004446 |
| [1] |
陈典, 隆寰宇, 张丛溪, 等. 2025年GOLD慢性阻塞性肺疾病诊断、治疗、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2025, 28(16): 1937-1949.
CHEN D, LONG H Y, ZHANG C X, 等. Interpretation of global strategy for the diagnosis, treatment, management and prevention of chronic obstructive pulmonary disease 2025 report[J]. Chinese General Practice, 2025, 28(16): 1937-1949.
|
| [2] |
周晓苹, 方荣华. 全科病房慢性阻塞性肺疾病患者焦虑抑郁状况调查及影响因素分析[J]. 中华全科医学, 2022, 20(6): 1003-1006. doi: 10.16766/j.cnki.issn.1674-4152.002510
ZHOU X P, FANG R H. Investigation and analysis of factors affecting anxiety and depression in patients with chronic obstructive pulmonary disease in general wards[J]. Chinese Journal of General Practice, 2022, 20(6): 1003-1006. doi: 10.16766/j.cnki.issn.1674-4152.002510
|
| [3] |
李庆云, 孙娴雯. 慢性阻塞性肺疾病稳定期管理的几个新视点: 2021版GOLD指南解读[J]. 诊断学理论与实践, 2021, 20(1): 43-47.
LI Q Y, SUN X W. Several new perspectives on the management of stable chronic obstructive pulmonary disease: interpretation of the 2021 GOLD guideline[J]. Diagnostics Theory and Practice, 2021, 20(1): 43-47.
|
| [4] |
王海静, 李静, 王永红, 等. 慢性阻塞性肺疾病患者外周血核苷酸结合寡聚化结构域样受体蛋白3水平与肺功能、病情程度和预后的关系[J]. 新乡医学院学报, 2022, 39(9): 847-850.
WANG H J, LI J, WANG Y H, et al. Relationship between peripheral blood NLRP3 level and pulmonary function, disease severity and prognosis in patients with chronic obstructive pulmonary disease[J]. Journal of Xinxiang Medical University, 2022, 39(9): 847-850.
|
| [5] |
QUOC Q L, CAO T B T, MOON J Y, et al. Contribution of monocyte and macrophage extracellular traps to neutrophilic airway inflammation in severe asthma[J]. Allergol Int, 2024, 73(1): 81-93. doi: 10.1016/j.alit.2023.06.004
|
| [6] |
LI C L, LIU S F. Exploring molecular mechanisms and biomarkers in COPD: an overview of current advancements and perspectives[J]. Int J Mol Sci, 2024, 25(13): 7347. DOI: 10.3390/ijms25137347.
|
| [7] |
BELOV V A, KARPOVA E P, ASMANOV A I, et al. Treatment of chronic tonsillitis: a personalized approach to prevent metatonsillar complications[J]. Pharmateca, 2025, 32(7): 45-52.
|
| [8] |
SHAMIM A, ABDUL AZIZ M, SAEED F, et al. Revisiting surfactant protein D: an immune surveillance molecule bridging innate and adaptive immunity[J]. Front Immunol, 2024, 15: 1491175. DOI: 10.3389/fimmu.2024.1491175.
|
| [9] |
AHMED M, ISLAM M S, SULTANA S, et al. Association of Chlamydia trachomatis infection with tubal occlusion in primary infertile women: A cross-sectional study using hysterosalpingography[J]. J Obstet Gynaecol Res, 2024, 50(8): 2891-2898.
|
| [10] |
SPRUIT M A, SINGH S J, GARVEY C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation[J]. Am J Respir Crit Care Med, 2013, 188(8): e13-e64. doi: 10.1164/rccm.201309-1634ST
|
| [11] |
URBAN M H, STOJKOVIC S, DEMYANETS S, et al. Soluble ST2 and all-cause mortality in patients with chronic obstructive pulmonary disease: a 10-year cohort study[J]. J Clin Med, 2021, 11(1): 56. DOI: 10.3390/jcm11010056.
|
| [12] |
POPETIU R O, DONATH-MIKLOS I, BORTA S M, et al. Serum YKL-40 levels, leukocyte profiles, and acute exacerbations of advanced COPD[J]. J Clin Med, 2023. DOI: 10.3390/jcm12186106.
|
| [13] |
PASE M P, HIMALI J J, PUERTA R, et al. Association of plasma YKL-40 with MRI, CSF, and cognitive markers of brain health and dementia[J]. Neurology, 2024, 102(4): e208075. DOI: 10.1212/WNL.0000000000208075.
|
| [14] |
ZHANG J, CHEN F, WAN Y, et al. Early detection and prediction of acute exacerbation of chronic obstructive pulmonary disease[J]. Chin Med J Pulmon Crit Care Med, 2023, 1(2): 102-107. doi: 10.1016/j.pccm.2023.04.004
|
| [15] |
QIAN Y, CAI C T, SUN M Q, et al. Analyses of factors associated with acute exacerbations of chronic obstructive pulmonary disease: a review[J]. Int J Chron Obstruct Pulmon Dis, 2023, 18: 2707-2723. doi: 10.2147/COPD.S433183
|
| [16] |
ZHANG C, LING W, PAN H, et al. Prediction of 12-month exacerbation-related readmission in hospitalized patients with COPD: a single-center study in China[J]. Eur J Med Res, 2025, 30(1): 773. doi: 10.1186/s40001-025-03042-z
|
| [17] |
FAN J, FANG L W, CONG S, et al. Potential pre-COPD indicators in association with COPD development and COPD prediction models in Chinese: a prospective cohort study[J]. Lancet Reg Health West Pac, 2024, 44: 100984. DOI: 10.1016/j.lanwpc.2023.100984.
|